))
Drug Monitoring in Behavioral Health and during times of crisis
アーカイブされたシリーズ ("無効なフィード" status)
When?
This feed was archived on January 03, 2024 08:08 (
Why? 無効なフィード status. サーバーは持続期間に有効なポッドキャストのフィードを取得することができませんでした。
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 282121265 series 2854810
コンテンツは questdrugtesting によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、questdrugtesting またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作権で保護された作品をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:
- Mental Health disorders, diagnosis and prevalence
- The challenge of medication adherence in mental health treatment
- The impact of crises on the treatment of patients with mental health conditions
- The role of clinical drug monitoring
The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.
----more----
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
23 つのエピソード
シェア
